BRIEF published on 09/02/2026 at 07:35, 6 days 17 hours ago Nicox Étend Son Horizon de Trésorerie Grâce à NCX 470 Ophtalmologie NDA Nicox NCX 470 Horizon De Trésorerie
BRIEF published on 09/02/2026 at 07:35, 6 days 17 hours ago Nicox annonce une prolongation de sa stabilité financière Mise À Jour Financière Ophtalmologie Nicox NCX 470 Routine De Trésorerie
BRIEF published on 09/02/2026 at 07:35, 6 days 17 hours ago Nicox Announces Financial Stability Extension Financial Update Ophthalmology Nicox NCX 470 Cash Runway
BRIEF published on 09/02/2026 at 07:35, 6 days 17 hours ago Nicox Extends Its Cash Flow Horizon Thanks to NCX 470 Ophthalmology NDA Nicox NCX 470 Cash Flow Horizon
PRESS RELEASE published on 09/02/2026 at 07:30, 6 days 17 hours ago Nicox Announces Extension of Cash Runway Nicox extends cash runway with estimated €8.4 million as of 31 August 2026, supporting operations beyond Q1 2028. NCX 470 U.S. NDA approval milestone could fund operations into 2029 Financial Update Ophthalmology Nicox NCX 470 Cash Runway
PRESS RELEASE published on 09/02/2026 at 07:30, 6 days 17 hours ago Nicox annonce l’extension de son horizon de trésorerie Nicox annonce l’extension de son horizon de trésorerie jusqu'en 2029 grâce aux revenus attendus et au paiement d'étape pour NCX 470 aux Etats-Unis. Discussions sur les opportunités stratégiques en cours Trésorerie Revenus Nicox NCX 470 Opportunités Stratégiques
BRIEF published on 08/27/2026 at 07:35, 12 days 17 hours ago Nicox : Date PDUFA fixée pour le NCX 470 en avril 2027 FDA Nicox NCX 470 Glaucome PDUFA
BRIEF published on 08/27/2026 at 07:35, 12 days 17 hours ago Nicox: PDUFA date set for the NCX 470 in April 2027 FDA Glaucoma Nicox NCX 470 PDUFA
PRESS RELEASE published on 08/27/2026 at 07:30, 12 days 17 hours ago Nicox annonce avril 2027 comme date PDUFA pour NCX 470 dans le traitement du glaucome Nicox annonce la date PDUFA d'avril 2027 pour NCX 470 dans le traitement du glaucome. Deux NDAs déposées, lancements prévus en 2027 Traitement Nicox NCX 470 Glaucome PDUFA
PRESS RELEASE published on 08/27/2026 at 07:30, 12 days 17 hours ago Nicox Announces April 2027 PDUFA Date for NCX 470 in Glaucoma Nicox announces April 2027 PDUFA date for NCX 470 in Glaucoma. Positive results from Phase 3 trials pave the way for potential FDA approval and commercial launch in H2 2027 FDA Approval Glaucoma Nicox NCX 470 PDUFA Date
Published on 09/09/2026 at 00:35, 14 minutes ago Troubadour Resources Announces Non-Brokered Unit Private Placement and Convertible Debenture Financing
Published on 09/09/2026 at 00:25, 24 minutes ago Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress
Published on 09/08/2026 at 23:35, 1 hour 14 minutes ago The Western Investment Company of Canada Limited Announces Intention to Commence Normal Course Issuer Bid
Published on 09/08/2026 at 22:30, 2 hours 19 minutes ago Grid Metals Announces Positive Mineralogical Results at Falcon West, Engages SGS Canada for Ore Sorting Test Work, and Announces Investor Relations Agreements
Published on 09/08/2026 at 22:15, 2 hours 34 minutes ago GameSquare Regains Compliance with Nasdaq's Minimum Bid Price Requirement
Published on 09/08/2026 at 22:50, 1 hour 58 minutes ago Cataneo Set to Unveil the Future of AI Engagement at IBC2026 in Amsterdam
Published on 09/08/2026 at 22:05, 2 hours 43 minutes ago oneworld Partners with Popular App Timeshifter to Help Round the World Travellers Beat Jet Lag
Published on 09/08/2026 at 18:30, 6 hours 19 minutes ago Avolta extends long-term travel retail contracts across four Mexican airports
Published on 09/08/2026 at 17:45, 7 hours 4 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 août 2026
Published on 09/08/2026 at 17:45, 7 hours 4 minutes ago Chiffre d’affaires semestriel consolidé 2026 : 71,8 M€
Published on 09/08/2026 at 11:00, 13 hours 49 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 09/08/2026 at 11:00, 13 hours 49 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
